{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:51:48Z","timestamp":1792601508447,"version":"4.5.0"},"update-to":[{"DOI":"10.1002\/14651858.cd007746","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2015,12,3]],"date-time":"2015-12-03T00:00:00Z","timestamp":1449100800000}}],"reference-count":231,"publisher":"Wiley","issue":"12","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd007746.pub2","type":"journal-article","created":{"date-parts":[[2015,12,3]],"date-time":"2015-12-03T22:06:51Z","timestamp":1449180411000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Mycophenolic acid versus azathioprine as primary immunosuppression for kidney transplant recipients"],"prefix":"10.1002","volume":"2015","author":[{"given":"Martin","family":"Wagner","sequence":"first","affiliation":[{"name":"University Hospital W\u00fcrzburg; Department of Medicine I, Division of Nephrology; Oberd\u00fcrrbacher Str. 6 W\u00fcrzburg Germany 97080"},{"name":"University of W\u00fcrzburg; Institute of Clinical Epidemiology and Biometry; W\u00fcrzburg Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy K","family":"Earley","sequence":"additional","affiliation":[{"name":"Tufts Medical Center; Institute for Clinical Research and Health Policy Studies; 800 Washington St Boston MA USA 02113"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela C","family":"Webster","sequence":"additional","affiliation":[{"name":"The University of Sydney; Sydney School of Public Health; Edward Ford Building A27 Sydney NSW Australia 2006"},{"name":"The University of Sydney at Westmead; Centre for Transplant and Renal Research, Westmead Millennium Institute; Westmead NSW Australia 2145"},{"name":"The Children's Hospital at Westmead; Cochrane Kidney and Transplant, Centre for Kidney Research; Westmead NSW Australia 2145"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher H","family":"Schmid","sequence":"additional","affiliation":[{"name":"Brown University School of Public Health; Center for Evidence-based Medicine; Providence RI USA 02912"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan M","family":"Balk","sequence":"additional","affiliation":[{"name":"Brown University School of Public Health; Center for Evidence-based Medicine; Providence RI USA 02912"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Uhlig","sequence":"additional","affiliation":[{"name":"Tufts University School of Medicine; Department of Medicine, Division of Nephrology; 750 Washington St Box 391 Boston MA USA 02111"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,12,3]]},"reference":[{"issue":"4","key":"10.1002\/14651858.CD007746.pub2-BIB0001|cit1","first-page":"226","article-title":"Mycophenolate versus AZA-in-de-nova renal transplantation - a short term study [abstract]","volume":"12","author":"Army Hospital (R&R)","year":"2002","journal-title":"Indian Journal of Nephrology"},{"issue":"3","key":"10.1002\/14651858.CD007746.pub2-BIB0002|cit2","first-page":"262","article-title":"Changes in health-related quality of life in the first year of kidney transplantation","volume":"22","author":"Baltar","year":"2002","journal-title":"Nefrologia"},{"issue":"9","key":"10.1002\/14651858.CD007746.pub2-BIB0003|cit3","first-page":"A274","article-title":"Health related quality of life (HRQOL) in two inmunosuppressor therapy regimens [abstract]","volume":"14","author":"Baltar","year":"1999","journal-title":"Nephrology Dialysis Transplantation"},{"key":"10.1002\/14651858.CD007746.pub2-BIB0005|cit4","unstructured":"Busque S Shoker A Landsberg D McAlister V Halloran P Shapiro J Canadian multicentre kidney trial of prograf\/AZA vs. neoral\/MMF [abstract] XVIII International Congress of the Transplantation Society; 2000 Aug 27-Sept 1; Rome, Italy 2000"},{"issue":"8 Suppl","key":"10.1002\/14651858.CD007746.pub2-BIB0006|cit5","doi-asserted-by":"crossref","first-page":"S114","DOI":"10.1097\/00007890-200004271-00014","article-title":"Canadian multicentre trial of prograf\/AZA vs. prograf\/MMF vs. Neoral\/MMF in renal transplantation [abstract]","volume":"69","author":"Busque","year":"2000","journal-title":"Transplantation"},{"issue":"1-2","key":"10.1002\/14651858.CD007746.pub2-BIB0004|cit6","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/S0041-1345(00)02471-4","article-title":"Canadian multicentre trial of tacrolimus\/azathioprine\/steroids versus tacrolimus\/mycophenolate mofetil\/steroids versus neoral\/mycophenolate mofetil\/steroids in renal transplantation","volume":"33","author":"Busque","year":"2001","journal-title":"Transplantation Proceedings"},{"issue":"6","key":"10.1002\/14651858.CD007746.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1016\/S0041-1345(03)00815-7","article-title":"36-month follow-up of 75 renal allograft recipients treated with steroids, tacrolimus, and azathioprine or mycophenolate mofetil","volume":"35","author":"Mucha","year":"2003","journal-title":"Transplantation Proceedings"},{"key":"10.1002\/14651858.CD007746.pub2-BIB0008|cit8","unstructured":"Wlodarczyk Z Glyda M Paczek L Ostrowski M Marcinkowski W Klinger M Long-term results of steroid withdrawal following renal transplantation in tacrolimus-based immunosuppression regimens - results of multicenter study [abstract no: 25] 3rd International Congress on Immunosuppression; 2004 Dec 8-11; San Diego, CA 2004"},{"key":"10.1002\/14651858.CD007746.pub2-BIB0011|cit9","unstructured":"Wlodarczyk Z Walaszewski J Perner F Vitko S Ostrowski M Tacrolimus\/MMF\/steroids compared to tacrolimus\/AZA\/steroids in renal transplantation: differences in efficacy and feasibility of steroid withdrawal [abstract] XIXth International Congress of the Transplantation Society; 2002 Aug 25-30; Miami, FL 2002"},{"issue":"3","key":"10.1002\/14651858.CD007746.pub2-BIB0009|cit10","first-page":"28","article-title":"Freedom from rejection and stable kidney function are excellent criteria for steroid withdrawal in tacrolimus-treated kidney transplant recipients","volume":"7","author":"Wlodarczyk","year":"2002","journal-title":"Annals of Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD007746.pub2-BIB0010|cit11","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1432-2277.2004.00011.x","article-title":"Steroid withdrawal at 3 months after kidney transplantation: a comparison of two tacrolimus-based regimens","volume":"18","author":"Wlodarczyk","year":"2005","journal-title":"Transplant International"},{"issue":"Suppl 5","key":"10.1002\/14651858.CD007746.pub2-BIB0012|cit12","first-page":"556","article-title":"Freedom from rejection and stable renal function are excellent criteria for steroid withdrawal in tacrolimus therapy [abstract]","volume":"3","author":"Wlodarczyk","year":"2003","journal-title":"American Journal of Transplantation"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD007746.pub2-BIB0013|cit13","first-page":"727A","article-title":"Mycophenolate mofetil (MMF) vs azathioprin (AZA) in combination with prednisone, cyclosporin, and ATGAM for prevention of acute renal graft rejection [abstract]","volume":"10","author":"Egfjord","year":"1999","journal-title":"Journal of the American Society of Nephrology"},{"issue":"9","key":"10.1002\/14651858.CD007746.pub2-BIB0014|cit14","first-page":"A275","article-title":"Open randomized study of mofetil vs azathioprin combined with prednisone and cyclosporin for prevention of acute renal graft rejection [abstract]","volume":"14","author":"Ladefoged","year":"1999","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"7-8","key":"10.1002\/14651858.CD007746.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1016\/S0041-1345(01)02366-1","article-title":"Low rate of acute rejection and cytomegalovirus infection in kidney transplant recipients with basiliximab","volume":"33","author":"Folkmane","year":"2001","journal-title":"Transplantation Proceedings"},{"issue":"2","key":"10.1002\/14651858.CD007746.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S0041-1345(01)02845-7","article-title":"Results of renal transplantation with different immunosuppressive regimens","volume":"34","author":"Folkmane","year":"2002","journal-title":"Transplantation Proceedings"},{"issue":"3","key":"10.1002\/14651858.CD007746.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1016\/S0041-1345(01)02031-0","article-title":"beta-herpes virus activation after kidney transplantation with mycophenolate mofetil-based maintenance immunosuppression","volume":"33","author":"Folkmane","year":"2001","journal-title":"Transplantation Proceedings"},{"key":"10.1002\/14651858.CD007746.pub2-BIB0018|cit18","unstructured":"Folkmane I Chapenko S Murovska M Rosental R Low rate of acute rejection and cytomegalovirus infection in renal transplant recipients with basiliximab [abstract no: 1037] A Transplant Odyssey; 2001 Aug 20-23; Istanbul, Turkey 2001"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD007746.pub2-BIB0019|cit19","first-page":"S327","article-title":"Mycophenolate mofetil suppresses the humoral response to influenza vaccination in renal transplant recipients [abstract no: P1014]","volume":"3","author":"Isbel","year":"1997","journal-title":"Nephrology"},{"issue":"3","key":"10.1002\/14651858.CD007746.pub2-BIB0020|cit20","first-page":"215","article-title":"The clinical investigation of mycophenolate mofetil for the prevention of acute rejection","volume":"22","author":"Ji","year":"2001","journal-title":"Academic Journal of Sun Yat-Sen University of Medical Sciences"},{"issue":"1","key":"10.1002\/14651858.CD007746.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3346\/jkms.2005.20.1.79","article-title":"The influence of mycophenolate mofetil and azathioprine on the same cadaveric donor renal transplantation","volume":"20","author":"Joh","year":"2005","journal-title":"Journal of Korean Medical Science"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD007746.pub2-BIB0022|cit22","first-page":"A18","article-title":"The influence of mycophenolate (MMF) and azathioprine (AZA) in the same cadaveric renal transplantation [abstract no: FC5-01]","volume":"8","author":"Kim","year":"2003","journal-title":"Nephrology"},{"issue":"2","key":"10.1002\/14651858.CD007746.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/00007890-200107270-00014","article-title":"Randomized trial of tacrolimus plus mycophenolate mofetil or azathioprine versus cyclosporine oral solution (modified) plus mycophenolate mofetil after cadaveric kidney transplantation: results at 2 years","volume":"72","author":"Ahsan","year":"2001","journal-title":"Transplantation"},{"issue":"12","key":"10.1002\/14651858.CD007746.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1097\/00007890-199806270-00375","article-title":"Diabetes mellitus with neoral (cyclosporine) vs. prograf (tacrolimus) based regimens after kidney transplant [abstract no: 356]","volume":"65","author":"Ahsan","year":"1998","journal-title":"Transplantation"},{"issue":"12","key":"10.1002\/14651858.CD007746.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1097\/01.TP.0000069831.76067.22","article-title":"Randomized trial of tacrolimus + mycophenolate mofetil or azathioprine versus cyclosporine + mycophenolate mofetil after cadaveric kidney transplantation: results at three years","volume":"75","author":"Gonwa","year":"2003","journal-title":"Transplantation"},{"issue":"7","key":"10.1002\/14651858.CD007746.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"S239","DOI":"10.1097\/00007890-199904150-00954","article-title":"Comparative trial of prograf (tacrolimus) in combination with azathioprine or mycophenolate mofetil vs neoral (cyclosporine) with mycophenolate mofetil after kidney transplantation [abstract no: 930]","volume":"67","author":"Gonwa","year":"1999","journal-title":"Transplantation"},{"key":"10.1002\/14651858.CD007746.pub2-BIB0027|cit27","unstructured":"Gonwa TA FK506\/MMF Study Trial Group Two year follow-up of a randomized trial of FK506 + MMF vs FK506 + AZA vs CyA + MMF [abstract] XVIII International Congress of the Transplantation Society; 2000 Aug 27-Sep 1; Rome, Italy 2000"},{"issue":"8 Suppl","key":"10.1002\/14651858.CD007746.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"S113","DOI":"10.1097\/00007890-200004271-00011","article-title":"Two year follow up of a randomised multicenter kidney transplant study comparing tacrolimus (PG) + azathioprine (AZA) vs cyclosporin (Neoral) + mycophenolate mofetil (MMF) vs tacrolimus + MMF [abstract]","volume":"69","author":"Gonwa","year":"2000","journal-title":"Transplantation"},{"issue":"12","key":"10.1002\/14651858.CD007746.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"S168","DOI":"10.1097\/00007890-199806270-00681","article-title":"Randomized comparative trial of prograf (tacrolimus) in combination with azathioprine or mycophenolate mofetil vs. neoral (cyclosporine) with mycophenolate mofetil after kidney transplantation [abstract no: 662]","volume":"65","author":"Johnson","year":"1998","journal-title":"Transplantation"},{"issue":"5","key":"10.1002\/14651858.CD007746.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1097\/00007890-200003150-00028","article-title":"Randomized trial of tacrolimus (Prograf) in combination with azathioprine or mycophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantation","volume":"69","author":"Johnson","year":"2000","journal-title":"Transplantation"},{"key":"10.1002\/14651858.CD007746.pub2-BIB0031|cit31","first-page":"3A","article-title":"Randomized trial of Prograf+MMF or azathioprine versus neoral+MMF after cadaveric kidney transplantation: results at three years.[abstract no: F-FC012]","volume":"13","author":"Johnson","year":"2002","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Nov","key":"10.1002\/14651858.CD007746.pub2-BIB0032|cit32","first-page":"646A","article-title":"Immunoglobulin deficiency in kidney allograft recipients: comparative effects of mycophenolate mofetil and azathioprine [abstract]","volume":"14","author":"Keven","year":"2003","journal-title":"Journal of the American Society of Nephrology"},{"issue":"4","key":"10.1002\/14651858.CD007746.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1399-3062.2003.00035.x","article-title":"Immunoglobulin deficiency in kidney allograft recipients: comparative effects of mycophenolate mofetil and azathioprine","volume":"5","author":"Keven","year":"2003","journal-title":"Transplant Infectious Disease"},{"issue":"3","key":"10.1002\/14651858.CD007746.pub2-BIB0034|cit34","first-page":"175","article-title":"Combined use of MMF with low dosage of cyclosporine A in renal transplantation","volume":"19","author":"Ling","year":"1998","journal-title":"Chinese Journal of Organ Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD007746.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/S0041-1345(98)00244-9","article-title":"FK 506 and mycophenolate mofetil in renal transplant recipients: six-month results of a multicenter, randomized dose ranging trial. FK 506 MMF Dose-Ranging Kidney Transplant Study Group","volume":"30","author":"Mendez","year":"1998","journal-title":"Transplantation Proceedings"},{"issue":"1-2","key":"10.1002\/14651858.CD007746.pub2-BIB0038|cit36","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0041-1345(98)01625-X","article-title":"Tacrolimus and mycophenolate mofetil in renal transplant recipients: one year results of a multicenter, randomized dose ranging trial. FK506\/MMF Dose-Ranging Kidney Transplant Study Group","volume":"31","author":"Miller","year":"1999","journal-title":"Transplantation Proceedings"},{"issue":"12","key":"10.1002\/14651858.CD007746.pub2-BIB0036|cit37","doi-asserted-by":"crossref","first-page":"S190","DOI":"10.1097\/00007890-199806270-00771","article-title":"Tacrolimus and mycophenolate mofetil in renal transplant recipients: six and twelve month results of a multicenter, randomized dose ranging study [abstract no: 752]","volume":"65","author":"Miller","year":"1998","journal-title":"Transplantation"},{"issue":"5","key":"10.1002\/14651858.CD007746.pub2-BIB0037|cit38","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/00007890-200003150-00035","article-title":"Safety and efficacy of tacrolimus in combination with mycophenolate mofetil (MMF) in cadaveric renal transplant recipients. FK506\/MMF Dose-Ranging Kidney Transplant Study Group","volume":"69","author":"Miller","year":"2000","journal-title":"Transplantation"},{"key":"10.1002\/14651858.CD007746.pub2-BIB0039|cit39","unstructured":"Berge F Durang D Merville P Morel D Mourad G Potaux L Beneficial effect of mycophenolate mofetil on the incidence of chronic allograft nephropathy: a randomized protocol biopsy-based study [abstract no: 1614] A Transplant Odyssey; 2001 Aug 20-23; Istanbul, Turkey 2001"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD007746.pub2-BIB0040|cit40","first-page":"409","article-title":"Interest of mycophenolate mofetil in the prevention of chronic allograft nephropathy: a randomized biopsy-based study [abstract no: 1076]","volume":"2","author":"Merville","year":"2002","journal-title":"American Journal of Transplantation"},{"issue":"11","key":"10.1002\/14651858.CD007746.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1111\/j.1600-6143.2004.00533.x","article-title":"Lower incidence of chronic allograft nephropathy at 1 year post-transplantation in patients treated with mycophenolate mofetil","volume":"4","author":"Merville","year":"2004","journal-title":"American Journal of Transplantation"},{"issue":"6","key":"10.1002\/14651858.CD007746.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1016\/S0041-1345(02)02863-4","article-title":"Effect of mycophenolate mofetil on the prevention of acute renal allograft rejection","volume":"34","author":"Miladipour","year":"2002","journal-title":"Transplantation Proceedings"},{"issue":"7","key":"10.1002\/14651858.CD007746.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1097\/00007890-199604150-00008","article-title":"A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group","volume":"61","year":"1996","journal-title":"Transplantation"},{"issue":"7","key":"10.1002\/14651858.CD007746.pub2-BIB0044|cit44","first-page":"A1","article-title":"Mycophenolate vs azathioprine for kidney transplantation - 15 year follow-up of a randomised trial [abstract no: 111]","volume":"89","author":"Clayton","year":"2011","journal-title":"Immunology & Cell Biology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD007746.pub2-BIB0045|cit45","first-page":"69","article-title":"Mycophenolate vs azathioprine for kidney transplantation: 15 year follow-up of a randomized trial [abstract no: 172]","volume":"16","author":"Clayton","year":"2011","journal-title":"Nephrology"},{"issue":"2","key":"10.1002\/14651858.CD007746.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/TP.0b013e31825475a3","article-title":"Mycophenolate versus azathioprine for kidney transplantation: a 15-year follow-up of a randomized trial","volume":"94","author":"Clayton","year":"2012","journal-title":"Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD007746.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/00007890-199701150-00008","article-title":"Mycophenolate mofetil in renal allograft recipients: a pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection. The International Mycophenolate Mofetil Renal Transplant Study Groups. [erratum appears in Transplantation 1997 Feb 27;63(4):618]","volume":"63","author":"Halloran","year":"1997","journal-title":"Transplantation"},{"key":"10.1002\/14651858.CD007746.pub2-BIB0048|cit48","unstructured":"Hayry P International Mycophenolate Mofetil Renal Transplant Study Group Mycophenolate mofetil (MMF) for acute rejection of cadavers renal transplants: results of a randomized, double-blind, multicenter study [abstract] 14th Annual Meeting. American Society of Transplant Physicians (ASTP); 1995 May 14-17; Chicago, IL 1995"},{"key":"10.1002\/14651858.CD007746.pub2-BIB0049|cit49","unstructured":"International Mycophenolate Mofetil Study Group A long-term randomized multicenter study of mycophenolate mofetil (MMF) in cadaveric renal transplantation: results at 3 years [abstract] 16th Annual Meeting. American Society of Transplant Physicians (ASTP); 1997 May 10-14; Chicago, IL 1997 175"},{"key":"10.1002\/14651858.CD007746.pub2-BIB0050|cit50","unstructured":"Keown PA Sullivan SD Best JH Garrison LP Krueger H Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group Economic evaluation of mycophenolate mofetil (MMF) for prevention of acute graft rejection after cadaveric renal transplantation in Canada [abstract] 16th Annual Meeting. American Society of Transplant Physicians (ASTP); 1997 May 10-14; Chicago, IL 1997 239"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD007746.pub2-BIB0051|cit51","first-page":"S71","article-title":"Adverse event profile of mycophenolate mofetil (MMF) in cadaveric renal transplant patients - a 1-year follow-up [abstract]","volume":"3","author":"Mathew","year":"1997","journal-title":"Nephrology"},{"key":"10.1002\/14651858.CD007746.pub2-BIB0052|cit52","unstructured":"Mathew T International Mycophenolate Mofetil Renal Transplantation Study Group A randomized, double-blind, multicenter study of mycophenolate mofetil (MMF) for acute rejection of cadaveric renal transplants [abstract] ISN XIII International Congress of Nephrology; 1995 Jul 2-6; Madrid, Spain 1995 335"},{"issue":"11","key":"10.1002\/14651858.CD007746.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1097\/00007890-199806150-00007","article-title":"A blinded, long-term, randomized multicenter study of mycophenolate mofetil in cadaveric renal transplantation: results at three years. Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group. [erratum appears in Transplantation 1998 Sep 27;66(6):817]","volume":"65","author":"Mathew","year":"1998","journal-title":"Transplantation"},{"issue":"1-2","key":"10.1002\/14651858.CD007746.pub2-BIB0059|cit54","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0041-1345(96)00302-8","article-title":"Mycophenolate mofetil for the prevention of acute rejection of primary cadaveric kidney transplants: status of the MYC 1866 study at 1 year. The U.S. Mycophenolate Mofetil Study Group","volume":"29","year":"1997","journal-title":"Transplantation Proceedings"},{"issue":"2","key":"10.1002\/14651858.CD007746.pub2-BIB0060|cit55","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0272-6386(99)70358-6","article-title":"Mycophenolate mofetil in cadaveric renal transplantation. US Renal Transplant Mycophenolate Mofetil Study Group","volume":"34","year":"1999","journal-title":"American Journal of Kidney Diseases"},{"key":"10.1002\/14651858.CD007746.pub2-BIB0054|cit56","unstructured":"Ferguson RM US Renal Transplant Mycophenolate Mofetil Study Group Efficacy of mycophenolate mofetil for the prevention of acute rejection in first cadaveric renal transplantation. [abstract] ISN XIII International Congress of Nephrology; 1995 Jul 2-6; Madrid, Spain 1995 335"},{"key":"10.1002\/14651858.CD007746.pub2-BIB0055|cit57","unstructured":"Gonwa TA US Renal Transplant Mycophenolate Mofetil Study Group Safety of mycophenolate mofetil (MMF) vs azathioprine (AZA) in primary cadaveric renal transplant (Cad TX) [abstract] 14th Annual Meeting American Society of Transplant Physicians (ASTP); 1995 May 10-14;Chicago (IL) 1995"},{"issue":"1","key":"10.1002\/14651858.CD007746.pub2-BIB0056|cit58","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/00007890-199701150-00008","article-title":"Mycophenolate mofetil in renal allograft recipients: a pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection. The International Mycophenolate Mofetil Renal Transplant Study Groups. [erratum appears in Transplantation 1997 Feb 27;63(4):618]","volume":"63","author":"Halloran","year":"1997","journal-title":"Transplantation"},{"issue":"12","key":"10.1002\/14651858.CD007746.pub2-BIB0057|cit59","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1097\/00007890-199560120-00001","article-title":"Reduced human IgG anti-ATGAM antibody formation in renal transplant recipients receiving mycophenolate mofetil","volume":"60","author":"Kimball","year":"1995","journal-title":"Transplantation"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD007746.pub2-BIB0058|cit60","first-page":"S71","article-title":"Adverse event profile of mycophenolate mofetil (MMF) in cadaveric renal transplant patients - a 1-year follow-up [abstract]","volume":"3","author":"Mathew","year":"1997","journal-title":"Nephrology"},{"issue":"9","key":"10.1002\/14651858.CD007746.pub2-BIB0063|cit61","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1097\/00007890-199711150-00008","article-title":"Immunosuppressive therapy in high-risk transplant patients: dose-dependent efficacy of mycophenolate mofetil in African-American renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group","volume":"64","author":"Neylan","year":"1997","journal-title":"Transplantation"},{"key":"10.1002\/14651858.CD007746.pub2-BIB0062|cit62","unstructured":"Neylan JF Deierhoi MH Dose-dependent prevention of acute renal transplant rejection in African-Americans receiving mycophenolate mofetil (MMF) [abstract] 14th Annual Meeting. American Society of Transplant Physicians (ASTP); 1995 May 14-17; Chicago, IL 1995"},{"key":"10.1002\/14651858.CD007746.pub2-BIB0061|cit63","unstructured":"Neylan JF Deierhoi MH US Renal Transplant Mycophenolate Mofetil Study Group Dose-dependant prevention of acute renal transplant rejection in African-Americans receiving mycophenolate mofetil (MMF) [abstract] ISN XIII International Congress of Nephrology; 1995 Jul 2-6; Madrid, Spain 1995 390"},{"issue":"3","key":"10.1002\/14651858.CD007746.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00007890-199508000-00003","article-title":"Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group","volume":"60","author":"Sollinger","year":"1995","journal-title":"Transplantation"},{"issue":"10","key":"10.1002\/14651858.CD007746.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1681\/ASN.V8101592","article-title":"The cost effectiveness of mycophenolate mofetil in the first year after primary cadaveric transplant. U.S. Renal Transplant Mycophenolate Mofetil Study Group","volume":"8","author":"Sullivan","year":"1997","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1002\/14651858.CD007746.pub2-BIB0066|cit66","unstructured":"Tomlanovich S Cho S Hodge E Miller J Neylan J Hoofman L Mycophenolate mofetil in cadaveric renal transplantation: 3-year data [abstract] 16th Annual Meeting. American Society of Transplant Physicians (ASTP); 1997 May 10-14; Chicago, IL 1997 175"},{"key":"10.1002\/14651858.CD007746.pub2-BIB0067|cit67","unstructured":"Weinstein SS US Renal Transplant Mycophenolate Mofetil Study Group Safety of mycophenolate mofetil (MMF) vs. azathioprine (AZA) in primary cadaveric renal transplant (CAD TX) [abstract] ISN XIII International Congress of Nephrology; 1995 Jul 2-6; Madrid, Spain 1995 335"},{"issue":"5","key":"10.1002\/14651858.CD007746.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1016\/j.transproceed.2005.03.096","article-title":"Blood cyclosporine level soon after kidney transplantation is a major determinant of rejection: insights from the Mycophenolate Steroid-Sparing Trial","volume":"37","author":"Gotti","year":"2005","journal-title":"Transplantation Proceedings"},{"issue":"3","key":"10.1002\/14651858.CD007746.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1111\/j.1523-1755.2004.00471.x","article-title":"In renal transplantation blood cyclosporine levels soon after surgery act as a major determinant of rejection: insights from the MY.S.S. trial","volume":"65","author":"Perico","year":"2004","journal-title":"Kidney International"},{"issue":"Nov","key":"10.1002\/14651858.CD007746.pub2-BIB0070|cit70","first-page":"11A","article-title":"In renal transplantation low blood cyclosporine levels soon after surgery is a determinant of rejection: insights from the MY.S.S. trial [abstract]","volume":"14","author":"Perico","year":"2003","journal-title":"Journal of the American Society of Nephrology"},{"issue":"6","key":"10.1002\/14651858.CD007746.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1681\/ASN.2006101153","article-title":"Mycophenolate mofetil versus azathioprine for prevention of chronic allograft dysfunction in renal transplantation: the MYSS follow-up randomized, controlled clinical trial","volume":"18","author":"Remuzzi","year":"2007","journal-title":"Journal of the American Society of Nephrology"},{"issue":"9433","key":"10.1002\/14651858.CD007746.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0140-6736(04)16808-6","article-title":"Mycophenolate mofetil versus azathioprine for prevention of acute rejection in renal transplantation (MYSS): a randomised trial","volume":"364","author":"Remuzzi","year":"2004","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD007746.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/00007890-200208270-00013","article-title":"Short-term combination of mycophenolate mofetil with cyclosporine as a therapeutic option for renal transplant recipients: a prospective, multicenter, randomized study","volume":"74","author":"Sadek","year":"2002","journal-title":"Transplantation"},{"issue":"8 Suppl","key":"10.1002\/14651858.CD007746.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"S160","DOI":"10.1097\/00007890-200004271-00182","article-title":"Short-term combination of mycophenolate mofetil with cyclosporine as a safe therapeutic option for renal transplant recipients [abstract]","volume":"69","author":"Sadek","year":"2000","journal-title":"Transplantation"},{"issue":"7","key":"10.1002\/14651858.CD007746.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"S238","DOI":"10.1097\/00007890-199904150-00951","article-title":"Short-term mycophenolate mofetil combined with cyclosporine compared to standard maintenance regimens of cyclosporine with mycophenolate mofetil or azathioprine in kidney transplantation: interim analysis [abstract no: 927]","volume":"67","author":"Sadek","year":"1999","journal-title":"Transplantation"},{"key":"10.1002\/14651858.CD007746.pub2-BIB0076|cit76","doi-asserted-by":"crossref","unstructured":"Vogt B Sadek S Phase IV Neonatal Study Group Short-term combination of mycophenolate mofetil with cyclosporine as a safe therapeutive option in renal transplantation [abstract] XVIII International Congress of the Transplantation Society; 2000 Aug 27-Sep 1; Rome, Italy 2000","DOI":"10.1097\/00007890-200004271-00182"},{"issue":"7","key":"10.1002\/14651858.CD007746.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/S0041-1345(00)01388-9","article-title":"Safety and efficacy of mycophenolate mofetil for prophylaxis in Asian renal transplant recipients","volume":"32","author":"Suhail","year":"2000","journal-title":"Transplantation Proceedings"},{"issue":"Sept","key":"10.1002\/14651858.CD007746.pub2-BIB0078|cit78","first-page":"711A","article-title":"Does 6 months prophylaxis with mycophenolate mofetil reduce acute rejection in renal transplantation? [abstract]","volume":"11","author":"Vathsala","year":"2000","journal-title":"Journal of the American Society of Nephrology"},{"issue":"9","key":"10.1002\/14651858.CD007746.pub2-BIB0079|cit79","first-page":"544","article-title":"A comparison between therapeutic effects of mycophenolate mofetil and azathioprine in the management of patients after renal transplantation","volume":"21","author":"Sun","year":"2002","journal-title":"Yiyao Dao Bao [Herald of Medicine]"},{"issue":"6","key":"10.1002\/14651858.CD007746.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1016\/S0041-1345(02)02861-0","article-title":"Mycophenolate mofetil in renal transplantation: five years experience","volume":"34","author":"Tuncer","year":"2002","journal-title":"Transplantation Proceedings"},{"issue":"6","key":"10.1002\/14651858.CD007746.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.1432-2277.2011.01241.x","article-title":"Impact of maintenance immunosuppressive regimens--balance between graft protective suppression of immune functions and a near physiological immune response","volume":"24","author":"Weimer","year":"2011","journal-title":"Transplant International"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD007746.pub2-BIB0082|cit82","first-page":"120","article-title":"Impact of maintenance immunosuppressive regimens on immunological parameters of graft outcome [abstract no: P101]","volume":"20","author":"Weimer","year":"2007","journal-title":"Transplant International"},{"issue":"2 Suppl","key":"10.1002\/14651858.CD007746.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/01.tp.0000332655.67456.d3","article-title":"Different impact of maintenance immunosuppressive regimens on the immune response of renal transplant recipients [abstract no: 112]","volume":"86","author":"Weimer","year":"2008","journal-title":"Transplantation"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD007746.pub2-BIB0084|cit84","first-page":"66","article-title":"Impact of steroid withdrawal on the immune response of renal transplant recipients [abstract no: O-249]","volume":"22","author":"Weimer","year":"2009","journal-title":"Transplant International"},{"issue":"6","key":"10.1002\/14651858.CD007746.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.humimm.2014.02.015","article-title":"ATG induction in renal transplant recipients: Long-term hazard of severe infection is associated with long-term functional T cell impairment but not the ATG-induced CD4 cell decline","volume":"75","author":"Weimer","year":"2014","journal-title":"Human Immunology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD007746.pub2-BIB0086|cit86","first-page":"18","article-title":"Effects of three immunosuppressive regimens on immunological risk parameters: results of a prospective randomized study in renal transplant recipients [abstract no: 055]","volume":"17","author":"Weimer","year":"2002","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD007746.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1432-2277.2004.00047.x","article-title":"ATG induction therapy: long-term effects on Th1 but not on Th2 responses","volume":"18","author":"Weimer","year":"2005","journal-title":"Transplant International"},{"issue":"6","key":"10.1002\/14651858.CD007746.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1016\/S0041-1345(02)03278-5","article-title":"Effects of three immunosuppressive regimens on CD4 helper function, B cell monocyte and cytokine responses in renal transplant recipients: 4-month follow-up of a prospective randomized study","volume":"34","author":"Weimer","year":"2002","journal-title":"Transplantation Proceedings"},{"issue":"Suppl 11","key":"10.1002\/14651858.CD007746.pub2-BIB0089|cit89","first-page":"318","article-title":"sCD30 and neopterin as risk factors of chronic renal transplant rejection - impact of different immunosuppressive regimens [abstract no: 637]","volume":"5","author":"Weimer","year":"2005","journal-title":"American Journal of Transplantation"},{"issue":"Suppl 5","key":"10.1002\/14651858.CD007746.pub2-BIB0090|cit90","first-page":"v160","article-title":"sCD30 and neopterin as risk factors of chronic renal transplant rejection - impact of different immunosuppressive regimens [abstract no: SP424]","volume":"20","author":"Weimer","year":"2005","journal-title":"Nephrology Dialysis Transplantation"},{"key":"10.1002\/14651858.CD007746.pub2-BIB0091|cit91","doi-asserted-by":"crossref","unstructured":"Weimer R Suesal C Yildiz S Pelzl S Renner F Dietrich H SCD30 and neopterin as risk factors of chronic renal transplant rejection - impact of CsA, TACR and MMF [abstract] 3rd International Congress on Immunosuppression; 2004 Dec 8-11; San Diego, CA 2004","DOI":"10.1097\/00007890-200407271-00296"},{"issue":"2 Suppl","key":"10.1002\/14651858.CD007746.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/00007890-200407271-00296","article-title":"SCD30 and neopterin as risk factors of chronic renal transplant rejection - impact of different immunosuppressive regimens [abstract]","volume":"78","author":"Weimer","year":"2004","journal-title":"Transplantation"},{"issue":"8","key":"10.1002\/14651858.CD007746.pub2-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1111\/j.1600-6143.2006.01407.x","article-title":"Post-transplant sCD30 and neopterin as predictors of chronic allograft nephropathy: impact of different immunosuppressive regimens","volume":"6","author":"Weimer","year":"2006","journal-title":"American Journal of Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD007746.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1016\/j.transproceed.2005.02.088","article-title":"sCD30 and neopterin as risk factors of chronic renal transplant rejection: impact of cyclosporine A, tacrolimus, and mycophenolate mofetil","volume":"37","author":"Weimer","year":"2005","journal-title":"Transplantation Proceedings"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD007746.pub2-BIB0095|cit95","first-page":"719A","article-title":"Mycopheolate mofetil (MMF) in the treatment of chronic renal allograft rejection: a three-year follow-up [abstract]","volume":"10","author":"Araujo","year":"1999","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD007746.pub2-BIB0096|cit96","first-page":"18","article-title":"No benefit from mycophenolate mofetil in renal transplant recipients with chronic allograft nephropathy [abstract no: O56]","volume":"17","author":"Asci","year":"2002","journal-title":"Nephrology Dialysis Transplantation"},{"key":"10.1002\/14651858.CD007746.pub2-BIB0097|cit97","unstructured":"Baek H Huh W Kim JA Kim Y Kim DJ Oh H Efficacy of mycophenolate mofetil and azathiporine therapy in paired cadaveric renal transplantation: five-year experience [abstract] 41st Congress. European Renal Association. European Dialysis and Transplantation Association; 2004 May 15-18; Lisbon, Portugal 2004 402"},{"issue":"6","key":"10.1002\/14651858.CD007746.pub2-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1399-3062.2010.00533.x","article-title":"Cytomegalovirus risk factors in renal transplantation with modern immunosuppression","volume":"12","author":"Bataille","year":"2010","journal-title":"Transplant Infectious Disease"},{"issue":"4","key":"10.1002\/14651858.CD007746.pub2-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/00007890-199902270-00010","article-title":"Safety of kidney biopsy in pediatric transplantation: a report of the Controlled Clinical Trials in Pediatric Transplantation Trial of Induction Therapy Study Group","volume":"67","author":"Benfield","year":"1999","journal-title":"Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD007746.pub2-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1034\/j.1399-3046.1999.00003.x","article-title":"Mycophenolate mofetil in pediatric renal transplantation","volume":"3","author":"Benfield","year":"1999","journal-title":"Pediatric Transplantation"},{"issue":"3","key":"10.1002\/14651858.CD007746.pub2-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/j.1399-3046.2005.00296.x","article-title":"A randomized multicenter trial of OKT3 mAbs induction compared with intravenous cyclosporine in pediatric renal transplantation","volume":"9","author":"Benfield","year":"2005","journal-title":"Pediatric Transplantation"},{"key":"10.1002\/14651858.CD007746.pub2-BIB0104|cit102","doi-asserted-by":"crossref","unstructured":"Tejani A A randomized prospective multicenter trial of T-cell antibody induction therapy in pediatric renal transplantation [abstract] XVIII International Congress of the Transplantation Society; 2000 Aug 27-Sep 1; Rome, Italy 2000","DOI":"10.1097\/00007890-200004271-00001"},{"issue":"8 Suppl","key":"10.1002\/14651858.CD007746.pub2-BIB0102|cit103","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.1097\/00007890-200004271-00001","article-title":"A randomized prospective multicenter trial of T-cell antibody induction therapy in pediatric renal transplantation [abstract]","volume":"69","author":"Tejani","year":"2000","journal-title":"Transplantation"},{"issue":"Sept","key":"10.1002\/14651858.CD007746.pub2-BIB0103|cit104","first-page":"709A","article-title":"A randomized prospective multicenter trial of T-cell antibody induction therapy in pediatric renal transplantation [abstract]","volume":"11","author":"Tejani","year":"2000","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1002\/14651858.CD007746.pub2-BIB0105|cit105","first-page":"2975","article-title":"Mycophenolate mofetil in renal transplantation [abstract]","volume":"14","author":"Boletis","year":"1999","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"Suppl 8","key":"10.1002\/14651858.CD007746.pub2-BIB0106|cit106","first-page":"200","article-title":"Preemptive withdrawal of AZA or MMF prevents progression of BK viremia to BK nephropathy: a prospective randomized controlled trial of BK virus infection after renal transplantation [abstract]","volume":"4","author":"Agha","year":"2004","journal-title":"American Journal of Transplantation"},{"issue":"9","key":"10.1002\/14651858.CD007746.pub2-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1111\/j.1600-6143.2005.01000.x","article-title":"Donor origin of BK virus in renal transplantation and role of HLA C7 in susceptibility to sustained BK viremia","volume":"5","author":"Bohl","year":"2005","journal-title":"American Journal of Transplantation"},{"issue":"3","key":"10.1002\/14651858.CD007746.pub2-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1600-6143.2005.00742.x","article-title":"Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction.[erratum appears in Am J Transplant. 2005 Apr;5(4 Pt 1):839]","volume":"5","author":"Brennan","year":"2005","journal-title":"American Journal of Transplantation"},{"issue":"2 Suppl","key":"10.1002\/14651858.CD007746.pub2-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/00007890-200407271-01313","article-title":"High donor antibody level and HLA C7 predict sustained BK-polyoma viremia: results of a randomized prospective trial [abstract no: P817]","volume":"78","author":"Brennan","year":"2004","journal-title":"Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD007746.pub2-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/01.TP.0000162980.68628.5A","article-title":"A randomized, prospective, pharmacoeconomic trial of tacrolimus versus cyclosporine in combination with thymoglobulin in renal transplant recipients","volume":"80","author":"Hardinger","year":"2005","journal-title":"Transplantation"},{"issue":"8","key":"10.1002\/14651858.CD007746.pub2-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1097\/01.tp.0000260146.57898.9c","article-title":"Maintenance immunosuppression with mycophenolate mofetil and corticosteroids in pediatric kidney transplantation: temporary benefit but not without risk","volume":"83","author":"Cransberg","year":"2007","journal-title":"Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD007746.pub2-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1440-1797.2008.00988.x","article-title":"Safe conversion of mycophenolate mofetil to azathioprine in kidney transplant recipients with sirolimus-based immunosuppression","volume":"14","author":"El-Agroudy","year":"2009","journal-title":"Nephrology"},{"key":"10.1002\/14651858.CD007746.pub2-BIB0113|cit113","doi-asserted-by":"crossref","unstructured":"El-Dahshan K El-Agroudy A Wafa E Gad Z Safe conversion of mycophenolate mofetil to azathioprine in kidney transplant recipients with sirolimus-based immunosuppression [abstract no: Su711] World Congress of Nephrology; 2009 May 22-26; Milan, Italy 2009","DOI":"10.1111\/j.1440-1797.2008.00988.x"},{"issue":"3","key":"10.1002\/14651858.CD007746.pub2-BIB0114|cit114","first-page":"1082","article-title":"Mycophenolate mofetil (MMF) in pediatric (PED) renal transplantation (TX): a report of the PED MMF study group [abstract]","volume":"6","author":"Ettenger","year":"1995","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Suppl 5","key":"10.1002\/14651858.CD007746.pub2-BIB0115|cit115","first-page":"223","article-title":"Renal function loss in chronic allograft nephropathy: results of a two-year study of mycophenolate mofetil substitution for azathioprine [abstract]","volume":"3","author":"Griffin","year":"2003","journal-title":"American Journal of Transplantation"},{"key":"10.1002\/14651858.CD007746.pub2-BIB0116|cit116","unstructured":"Ha J Yun IJ Lee JH Choi SJ Kang JM Kim SJ Azathioprine combination therapy can stably reduce cyclosporine dose as mycophenolate mofetil combination therapy for the recipients showing stable renal function after renal transplantation [abstract no: P-19] 3rd International Congress on Immunosuppression; 2004 Dec 8-11; San Diego (CA) 2004"},{"issue":"6","key":"10.1002\/14651858.CD007746.pub2-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1097\/01.tp.0000282872.17024.b7","article-title":"Randomized controlled study comparing reduced calcineurin inhibitors exposure versus standard cyclosporine-based immunosuppression","volume":"84","author":"Hernandez","year":"2007","journal-title":"Transplantation"},{"issue":"3","key":"10.1002\/14651858.CD007746.pub2-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1016\/S0041-1345(01)01928-5","article-title":"Chronic allograft nephropathy: a prospective randomised trial of cyclosporin reduction with or without mycophenolate mofetil","volume":"33","author":"Jain","year":"2001","journal-title":"Transplantation Proceedings"},{"key":"10.1002\/14651858.CD007746.pub2-BIB0119|cit119","unstructured":"Jain S Metcalfe M White SA Furness PN Nicholson ML Randomized trial comparing mycophenolate mofetil and azathioprine to allow cyclosporin reduction in chronic allograft nephropathy [abstract no: PO513W] XVIII International Congress of the Transplantation Society; 2000 Aug 27-Sep 1; Rome, Italy 2000"},{"issue":"8 Suppl","key":"10.1002\/14651858.CD007746.pub2-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"S227","DOI":"10.1097\/00007890-200004271-00437","article-title":"Chronic allograft nephropathy: a prospective randomised trial of cyclosporin reduction with or without mycophenolate mofetil [abstract no: 437]","volume":"69","author":"Nicholson","year":"2000","journal-title":"Transplantation"},{"issue":"7","key":"10.1002\/14651858.CD007746.pub2-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1016\/S0041-1345(00)01549-9","article-title":"The treatment of chronic rejection with mycophenolate mofetil versus azathioprine in kidney transplantation","volume":"32","author":"Jirasiritham","year":"2000","journal-title":"Transplantation Proceedings"},{"key":"10.1002\/14651858.CD007746.pub2-BIB0122|cit122","unstructured":"Kasiske BL Johnson HJ Heim-Duthoy KL Rao VK Dahl DC Jacobs DM Does mycophenolate mofetil improve already good results from cyclosporine induction early after renal transplantation? [abstract] 16th Annual Meeting. American Society of Transplant Physicians (ASTP); 1997 May 10-14; Chicago (ILL) 1997 236"},{"issue":"7","key":"10.1002\/14651858.CD007746.pub2-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/j.transproceed.2006.06.043","article-title":"Effects of azathioprine and mycophenolate mofetil-immunosuppressive regimens on the erythropoietic system of renal transplant recipients","volume":"38","author":"Khosroshahi","year":"2006","journal-title":"Transplantation Proceedings"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD007746.pub2-BIB0124|cit124","first-page":"iv263","article-title":"Effects of azathioprine and mycophenolate mofetil based immunosuppressive regimen on the erthropoietic system of the renal transplant recipients [abstract no: SP735]","volume":"21","author":"Khosroshahi","year":"2006","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD007746.pub2-BIB0125|cit125","first-page":"734A","article-title":"Clinical observation of mycophenolate mofetil for the prevention of acute rejection in renal transplantation [abstract]","volume":"10","author":"Kim","year":"1999","journal-title":"Journal of the American Society of Nephrology"},{"issue":"5","key":"10.1002\/14651858.CD007746.pub2-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1097\/00007890-199609150-00022","article-title":"Pharmacodynamic assessment of mycophenolic acid-induced immunosuppression in renal transplant recipients","volume":"62","author":"Langman","year":"1996","journal-title":"Transplantation"},{"issue":"2 Suppl","key":"10.1002\/14651858.CD007746.pub2-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/00007890-200407271-00712","article-title":"Conversion of azathioprine to mycophenolate mofetil and chronic graft failure progression [abstract]","volume":"78","author":"Lezaic","year":"2004","journal-title":"Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD007746.pub2-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.transproceed.2004.12.142","article-title":"Conversion of azathioprine to mycophenolate mofetil and chronic graft failure progression","volume":"37","author":"Lezaic","year":"2005","journal-title":"Transplantation Proceedings"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD007746.pub2-BIB0129|cit129","first-page":"A209","article-title":"Mycophenolate mofetil - a solution for cyclosporine induced hypertension in kidney transplanted patients? [abstract no: T-PO50008]","volume":"10","author":"Eilts","year":"2005","journal-title":"Nephrology"},{"issue":"2 Suppl","key":"10.1002\/14651858.CD007746.pub2-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1097\/00007890-200407271-01786","article-title":"Mycophenolate mofetil- a solution for cyclosporine induced hypertension in kidney transplanted patients? [abstract]","volume":"78","author":"Lison","year":"2004","journal-title":"Transplantation"},{"issue":"Suppl","key":"10.1002\/14651858.CD007746.pub2-BIB0131|cit131","first-page":"A216","article-title":"Comparison of 1 year allograft function with mycofenolate mofetil versus azathioprine in renal transplant patients [abstract no: T-PO50033]","volume":"10","author":"Makhdoomi","year":"2005","journal-title":"Nephrology"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD007746.pub2-BIB0132|cit132","first-page":"686A","article-title":"Long-term results of mycophenolate-mofetil (MMF) as compared to azathioprine (AZA) in renal transplantation [abstract]","volume":"9","author":"Mandelbaum","year":"1998","journal-title":"Journal of the American Society of Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD007746.pub2-BIB0133|cit133","first-page":"105","article-title":"Randomized, prospective trial of mycophenolate mofetil versus azathioprine for prevention of acute renal allograft rejection after simultaneous kidney-pancreas transplantation","volume":"70","author":"Merion","year":"2000","journal-title":"Transplantation"},{"key":"10.1002\/14651858.CD007746.pub2-BIB0134|cit134","unstructured":"Brook NR Metcalf MS Jain S Bicknell GR Nicholson ML Harper SJ A randomised trial of mycophenolate mofetil versus azathioprine as calcineurin inhibitor sparing agents in the treatment of chronic allograft nephropathy [abstract no: P-97] 3rd International Congress on Immunosuppression; 2004 Dec 8-11; San Diego (CA) 2004"},{"issue":"Suppl 8","key":"10.1002\/14651858.CD007746.pub2-BIB0135|cit135","first-page":"485","article-title":"A prospective randomised trial of mycophenolate mofetil and azathioprine after calcineurin reduction in renal allografts with established chronic allograft nephropathy [abstract]","volume":"4","author":"Brook","year":"2004","journal-title":"American Journal of Transplantation"},{"issue":"5","key":"10.1002\/14651858.CD007746.pub2-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1016\/S0041-1345(02)03088-9","article-title":"A randomized trial of mycophenolate mofetil versus azathioprine as calcineurin inhibitor sparing agents in the treatment of chronic allograft nephropathy","volume":"34","author":"Metcalfe","year":"2002","journal-title":"Transplantation Proceedings"},{"issue":"2","key":"10.1002\/14651858.CD007746.pub2-BIB0138|cit137","first-page":"235","article-title":"Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: The Mycophenolate Mofetil Acute Renal Rejection Study Group.[erratum appears in Transplantation 1998 Apr 15;65(7):followi]","volume":"65","year":"1998","journal-title":"Transplantation"},{"issue":"8","key":"10.1002\/14651858.CD007746.pub2-BIB0137|cit138","first-page":"1091","article-title":"Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: three-year follow-up. The Mycophenolate Mofetil Acute Renal Rejection Study Group","volume":"71","author":"Mycophenolate Mofetil Acute Renal Rejection Study Group","journal-title":"Transplantation"},{"issue":"7","key":"10.1002\/14651858.CD007746.pub2-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"S239","DOI":"10.1097\/00007890-199904150-00953","article-title":"Mycophenolate mofetil for the treatment of renal transplant rejection: 3 years of follow-up [abstract no: 929]","volume":"67","author":"Pescovitz","year":"1999","journal-title":"Transplantation"},{"key":"10.1002\/14651858.CD007746.pub2-BIB0140|cit140","unstructured":"Pirsch J Best JH 1912 Renal Transplant Mycophenolate Mofetil Study Group An economic evaluation of mycophenolate mofetil (MMF) versus azathioprine (AZA) as adjunctive treatment for acute renal allograft rejection [abstract] 16th Annual Meeting. American Society of Transplant Physicians (ASTP); 1997 May 10-14; Chicago (IL) 1997 239"},{"key":"10.1002\/14651858.CD007746.pub2-BIB0141|cit141","unstructured":"Pirsch JD Pescovitz MD Ferguson R Deierhoi M Hooftman L Navarro M Mycophenolate mofetil for the treatment of first acute renal allograft rejection [abstract] 16th Annual Meeting. American Society of Transplant Physicians (ASTP); 1997 May 10-14; Chicago (IL) 1997 261"},{"key":"10.1002\/14651858.CD007746.pub2-BIB0142|cit142","unstructured":"Balshaw R Marra C Nashan B Hagenmeyer EG Kalo Z Keown P Two-hour post-dose cyclosporine levels in renal transplantation: a cost-effective strategy for reducing graft rejection [abstract no: 3316] XIXth International Congress of the Transplantation Society; 2002 Aug 25-30; Miami (FL) 2002"},{"issue":"1","key":"10.1002\/14651858.CD007746.pub2-BIB0143|cit143","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/ndt\/gfi113","article-title":"Evolution of the absorption profile of cyclosporine A in renal transplant recipients: a longitudinal study of the de novo and maintenance phases","volume":"21","author":"Buchler","year":"2006","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD007746.pub2-BIB0144|cit144","first-page":"399","article-title":"Excellent renal tolerability of neoral C-2h monitoring in de novo kidney transplantation: initial results of the MO2ART trial [abstract no: 1038]","volume":"2","author":"Buchler","year":"2002","journal-title":"American Journal of Transplantation"},{"key":"10.1002\/14651858.CD007746.pub2-BIB0145|cit145","unstructured":"Chadban S Pilmore H Goodman D Hutchison B MO2ART SG Minimal rejection and excellent graft function by neoral C2 monitoring in renal transplantation: interim results of MO2ART [abstract] Transplantation Society of Australia & New Zealand (TSANZ). 21st Annual Scientific Meeting; 2003 Apr 9-11; Canberra, Australia 2003 65"},{"key":"10.1002\/14651858.CD007746.pub2-BIB0146|cit146","unstructured":"Chadban S Pilmore H Goodman D Jose M Hutchison B Cole E Optimal C2 targets after month 3 for renal transplant recipients receiving cyclosporin-microemulsion based triple therapy - the MO2ART trial [abstract no: 93] Transplantation Society of Australia & New Zealand (TSANZ). 22nd Annual Scientific Meeting; 2004 Mar 31-Apr 2; Canberra, Australia 2004 83"},{"key":"10.1002\/14651858.CD007746.pub2-BIB0147|cit147","unstructured":"Chadban S Pilmore H Goodman D Jose M Hutchison B MO2ART ISG Cyclosporin based immunosuppression with C2-monitoring for recipients with delayed graft function - MO2ART trial [abstract] Transplantation Society of Australia & New Zealand (TSANZ). 22nd Annual Scientific Meeting; 2004 Mar 31-Apr 2; Canberra, Australia 2004 33"},{"issue":"2 Suppl","key":"10.1002\/14651858.CD007746.pub2-BIB0148|cit148","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/00007890-200407271-00025","article-title":"Outcomes of 117 cases of delayed graft function from two clinical trials involving early C2 monitored neoral and antibody therapy [abstract]","volume":"78","author":"Curtis","year":"2004","journal-title":"Transplantation"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD007746.pub2-BIB0149|cit149","first-page":"399","article-title":"Monitoring of 2-hour neoral absorption in renal transplantation (MO2ART): interim analysis shows low incidence of acute rejection in the early post-graft period. [abstract no: 1037]","volume":"2","author":"Pfeffer","year":"2002","journal-title":"American Journal of Transplantation"},{"key":"10.1002\/14651858.CD007746.pub2-BIB0150|cit150","unstructured":"Pilmore H Chadban S G Goodman Jose Hutchison Improved efficacy and tolerability of neoral by C2-monitoring in de novo renal transplant recipients [abstract] Transplantation Society of Australia & New Zealand (TSANZ). 22nd Annual Scientific Meeting; 2004 Mar 31-Apr 2; Canberra, Australia 2004 96"},{"issue":"8","key":"10.1002\/14651858.CD007746.pub2-BIB0151|cit151","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1016\/j.transproceed.2007.08.087","article-title":"Quantification of interstitial fibrosis by image analysis on routine renal biopsy 1 year after transplantation in patients managed by C2 monitoring of cyclosporine microemulsion","volume":"39","author":"Servais","year":"2007","journal-title":"Transplantation Proceedings"},{"issue":"5","key":"10.1002\/14651858.CD007746.pub2-BIB0152|cit152","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/01.TP.0000153158.91683.34","article-title":"Efficacy and safety outcomes among de novo renal transplant recipients managed by C2 monitoring of cyclosporine a microemulsion: results of a 12-month, randomized, multicenter study","volume":"79","author":"Stefoni","year":"2005","journal-title":"Transplantation"},{"issue":"Suppl 8","key":"10.1002\/14651858.CD007746.pub2-BIB0153|cit153","first-page":"238","article-title":"Excellent efficacy and tolerability of cs-monitoring for cyclosporine microemulsion (CSA-ME, neoral): results of MO2ART, a 12-month randomized international study [abstract]","volume":"4","author":"Stefoni","year":"2004","journal-title":"American Journal of Transplantation"},{"issue":"6","key":"10.1002\/14651858.CD007746.pub2-BIB0154|cit154","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1097\/01.TP.0000089006.00653.64","article-title":"Clinical outcomes during the first three months posttransplant in renal allograft recipients managed by C2 monitoring of cyclosporine microemulsion","volume":"76","author":"Thervet","year":"2003","journal-title":"Transplantation"},{"key":"10.1002\/14651858.CD007746.pub2-BIB0155|cit155","unstructured":"Toselli L Peffer P Stefoni S Therver E Fornairon S Keown P Minimal rejection and excellent graft function by neoral c-2h monitoring in renal transplantation: interim results of MO2ART, a randomized prospective international study [abstract] XIXth International Congress of the Transplantation Society; 2002 Aug 25-30; Miami (FL) 2002"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD007746.pub2-BIB0156|cit156","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1111\/j.1432-2277.2000.tb02119.x","article-title":"Randomised open clinical trial of conversion from mycophenolate mofetil to azathioprine in cadaveric renal transplantation","volume":"13","author":"Nowacka-Cieciura","year":"2000","journal-title":"Transplant International"},{"issue":"9","key":"10.1002\/14651858.CD007746.pub2-BIB0157|cit157","first-page":"A276","article-title":"Lymphocyte subsets in peripheral blood and inside the allograft in renal tx treated with AZA versus MMF: CD3DR andICAM-1 down regulation with MMF [abstract]","volume":"14","author":"Oliveira","year":"1999","journal-title":"Nephrology Dialysis Transplantation"},{"key":"10.1002\/14651858.CD007746.pub2-BIB0158|cit158","unstructured":"Schurter G Glicklich D Greenstein SM Schreiber T Mallis M Clemetson S Mycophenolate mofetil (MMF) therapy for chronic rejection in renal transplant recipients [abstract] 16th Annual Meeting. American Society of Transplant Physicians (ASTP); 1997 May 10-14; Chicago (IL) 1997 133"},{"key":"10.1002\/14651858.CD007746.pub2-BIB0159|cit159","unstructured":"Smak Gregoor PJ van Gelder T van Besouw NM Van der mast P De kuiper P Ijzermans JN Long-term follow-up of a prospective, randomised study on minimising immunosuppressive medication from one year after kidney transplantation [abstract no: 0016] XIXth International Congress of the Transplantation Society; 2002 Aug 25-30; Miami (FL) 2002"},{"issue":"1","key":"10.1002\/14651858.CD007746.pub2-BIB0160|cit160","first-page":"143","article-title":"Randomized study on the conversion of treatment with cyclosporine to azathioprine or mycophenolate mofetil followed by dose reduction","volume":"70","author":"Smak Gregoor","year":"2000","journal-title":"Transplantation"},{"issue":"Suppl 5","key":"10.1002\/14651858.CD007746.pub2-BIB0161|cit161","first-page":"479","article-title":"Five-year follow-up of a prospective, randomised study on minimising immunosuppressive medication from one year after kidney transplantation [abstract no: 1276]","volume":"3","author":"Smak Gregoor","year":"2003","journal-title":"American Journal of Transplantation"},{"issue":"12","key":"10.1002\/14651858.CD007746.pub2-BIB0162|cit162","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1097\/00007890-199806270-00267","article-title":"Randomised trial comparing conversion of maintenance treatment with ciclosporine and prednisone to azathioprine or mycophenolate mofetil with prednisone one year after kidney transplantation [abstract no: 248]","volume":"65","author":"Gelder","year":"1998","journal-title":"Transplantation"},{"issue":"Suppl 11","key":"10.1002\/14651858.CD007746.pub2-BIB0163|cit163","first-page":"462","article-title":"Efficacy and safety of maintenance neoral monotherapy compared to bitherapy neoral+MMF or neoral+AZA in renal transplantation [abstract no: 1198]","volume":"5","author":"Touchard","year":"2005","journal-title":"American Journal of Transplantation"},{"key":"10.1002\/14651858.CD007746.pub2-BIB0164|cit164","unstructured":"Tsinalis D Binet I Dickenmann M Steiger J Brunner F Thiel G Cost of medical care after renal transplantation comparing cyclosporine-mycophenolate to tacrolimus-azathioprine - a randomised controlled study [abstract] XVIII International Congress of the Transplantation Society; 2000 Aug 27-Sep 1; Rome, Italy 2000"},{"issue":"11","key":"10.1002\/14651858.CD007746.pub2-BIB0165|cit165","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1111\/j.1600-6143.2008.02399.x","article-title":"Impact of immunosuppressive treatment on endothelial biomarkers after kidney transplantation","volume":"8","author":"Al-Massarani","year":"2008","journal-title":"American Journal of Transplantation"},{"key":"10.1002\/14651858.CD007746.pub2-BIB0166|cit166","doi-asserted-by":"crossref","first-page":"622","DOI":"10.12659\/AOT.889536","article-title":"Humoral immunity after kidney transplantation: impact of two randomized immunosuppressive protocols","volume":"18","author":"Legris","year":"2013","journal-title":"Annals of Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD007746.pub2-BIB0167|cit167","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/01.tp.0000229390.01369.4a","article-title":"Tacrolimus\/mycophenolate mofetil improved natural killer lymphocyte reconstitution one year after kidney transplant by reference to cyclosporine\/azathioprine","volume":"82","author":"Vacher-Coponat","year":"2006","journal-title":"Transplantation"},{"issue":"2 Suppl","key":"10.1002\/14651858.CD007746.pub2-BIB0168|cit168","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/01.tp.0000331137.03093.ae","article-title":"Cost effectiveness comparison for two immunosuppressive regimens in kidney transplantation [abstract no: 1634]","volume":"86","author":"Vacher-Coponat","year":"2008","journal-title":"Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD007746.pub2-BIB0169|cit169","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/TP.0b013e31824215b7","article-title":"A randomized trial with steroids and antithymocyte globulins comparing cyclosporine\/azathioprine versus tacrolimus\/mycophenolate mofetil (CATM2) in renal transplantation","volume":"93","author":"Vacher-Coponat","year":"2012","journal-title":"Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD007746.pub2-BIB0170|cit170","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1034\/j.1399-0012.2000.140112.x","article-title":"A longitudinal study of TGF-beta1 protein levels in renal allograft recipients converted from CsA to MMF or AZA","volume":"14","author":"Mast","year":"2000","journal-title":"Clinical Transplantation"},{"issue":"7A","key":"10.1002\/14651858.CD007746.pub2-BIB0171|cit171","doi-asserted-by":"crossref","first-page":"69S","DOI":"10.1016\/S0041-1345(99)00799-X","article-title":"Tacrolimus and mycophenolate mofetil in cadaveric renal transplant recipients. The European Multicentre Tacrolimus\/MMF Study Group","volume":"31","author":"Forsythe","year":"1999","journal-title":"Transplantation Proceedings"},{"issue":"7A","key":"10.1002\/14651858.CD007746.pub2-BIB0172|cit172","doi-asserted-by":"crossref","first-page":"75S","DOI":"10.1016\/S0041-1345(99)00801-5","article-title":"Tacrolimus, mycophenolate mofetil and corticosteroids as primary immunosuppression after renal transplantation at the Hospital 12 de Octubre, Madrid","volume":"31","author":"Morales","year":"1999","journal-title":"Transplantation Proceedings"},{"issue":"1","key":"10.1002\/14651858.CD007746.pub2-BIB0173|cit173","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00007890-200107150-00014","article-title":"Dose optimization of mycophenolate mofetil when administered with a low dose of tacrolimus in cadaveric renal transplant recipients","volume":"72","author":"Squifflet","year":"2001","journal-title":"Transplantation"},{"issue":"7A","key":"10.1002\/14651858.CD007746.pub2-BIB0174|cit174","doi-asserted-by":"crossref","first-page":"72S","DOI":"10.1016\/S0041-1345(99)00800-3","article-title":"The Benelux experience with the combination of tacrolimus and mycophenolate mofetil","volume":"31","author":"Squifflet","year":"1999","journal-title":"Transplantation Proceedings"},{"issue":"4","key":"10.1002\/14651858.CD007746.pub2-BIB0175|cit175","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/S0041-1345(98)00245-0","article-title":"Co-administration of tacrolimus and mycophenolate mofetil in cadaveric renal transplant recipients","volume":"30","author":"Vanrenterghem","year":"1998","journal-title":"Transplantation Proceedings"},{"issue":"5","key":"10.1002\/14651858.CD007746.pub2-BIB0176|cit176","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/S0041-1345(02)03035-X","article-title":"Benelux experience with a combination of tacrolimus and mycophenolate mofetil: 4-year results","volume":"34","author":"Hooff","year":"2002","journal-title":"Transplantation Proceedings"},{"issue":"5","key":"10.1002\/14651858.CD007746.pub2-BIB0177|cit177","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1016\/S0041-1345(02)03123-8","article-title":"Tacrolimus\/mycophenolate mofetil vs cyclosporine A\/azathioprine after simultaneous pancreas and kidney transplantation: five-year results of a randomized study","volume":"34","author":"Woeste","year":"2002","journal-title":"Transplantation Proceedings"},{"key":"10.1002\/14651858.CD007746.pub2-BIB0178|cit178","unstructured":"Woeste G Wullstein C Pridohl O Dette K Bechstein WO Five year results of a randomized study comparing FK506\/MMF and ciclosporin A\/azathioprine after simultaneous pancreas and kidney transplantation [abstract] 5th International Conference on New Trends in Clinical and Experimental Immunosuppression; 2002 Feb 7-10; Geneva, Switzerland 2002"},{"key":"10.1002\/14651858.CD007746.pub2-BIB0179|cit179","unstructured":"Binswanger U Ambuehl P Cicvara Muzar S Knoflach A Randomized conversion from Mycophenolate to Azathioprine: follow-up after 2 years. [abstract no: 1592] A Transplant Odyssey; 2001 Aug 20-23; Istanbul, Turkey 2001"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD007746.pub2-BIB0180|cit180","first-page":"896A","article-title":"Randomized conversion from mycophenolate mofetil to azathioprine: follow-up after 2 years [abstract]","volume":"12","author":"Inderbitzin","year":"2001","journal-title":"Journal of the American Society of Nephrology"},{"issue":"8","key":"10.1002\/14651858.CD007746.pub2-BIB0181|cit181","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1093\/ndt\/15.8.1228","article-title":"Randomized trial of conversion from mycophenolate mofetil to azathioprine 6 months after renal allograft transplantation","volume":"15","author":"Wuthrich","year":"2000","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"6","key":"10.1002\/14651858.CD007746.pub2-BIB0182|cit182","first-page":"949","article-title":"The influence of mycophenolate (MMF) and azathioprine (AZA) in the same cadaveric renal transplantation","volume":"20","author":"Do","year":"2001","journal-title":"Korean Journal of Nephrology"},{"key":"10.1002\/14651858.CD007746.pub2-BIB0183|cit183","unstructured":"Perico N A randomized, prospective, multicenter trial to compare the effect on chronic allograft nephropathy prevention of mycophenolate mofetil versus azathioprine as the sole immunosuppressive therapy for kidney transplant recipients www.clinicaltrials.gov\/ct2\/show\/NCT00494741"},{"issue":"7454","key":"10.1002\/14651858.CD007746.pub2-BIB0184|cit184","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"Atkins","year":"2004","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD007746.pub2-BIB0185|cit185","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1046\/j.1600-6143.2003.00321.x","article-title":"Enteric-coated mycophenolate sodium can be safely administered in maintenance renal transplant patients: results of a 1-year study","volume":"4","author":"Budde","year":"2004","journal-title":"American Journal of Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD007746.pub2-BIB0186|cit186","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1093\/ndt\/gfn605","article-title":"Immunosuppressive therapy and post-transplant malignancy","volume":"24","author":"Domhan","year":"2009","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD007746.pub2-BIB0187|cit187","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.trre.2003.08.004","article-title":"Graft survival benefit to be expected of new immunosuppressive regimens","volume":"17","author":"Ekberg","year":"2003","journal-title":"Transplantation Reviews"},{"issue":"8961","key":"10.1002\/14651858.CD007746.pub2-BIB0188|cit188","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/S0140-6736(95)92534-1","article-title":"Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. European Mycophenolate Mofetil Cooperative Study Group","volume":"345","year":"1995","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD007746.pub2-BIB0189|cit189","unstructured":"U.S Food Drug Administration CellCept (mycophenolate mofetil capsules) FDA Medwatch. 2008 http:\/\/www.fda.gov\/safety\/medwatch\/safetyinformation\/safety-relateddruglabelingchanges\/ucm119284.htm"},{"issue":"26","key":"10.1002\/14651858.CD007746.pub2-BIB0190|cit190","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1056\/NEJMra033540","article-title":"Immunosuppressive drugs for kidney transplantation","volume":"351","author":"Halloran","year":"2004","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD007746.pub2-BIB0191|cit191","doi-asserted-by":"crossref","first-page":"68","DOI":"10.5500\/wjt.v3.i4.68","article-title":"Novel immunosuppressive agents in kidney transplantation","volume":"3","author":"Hardinger","year":"2013","journal-title":"World Journal of Transplantation"},{"issue":"7414","key":"10.1002\/14651858.CD007746.pub2-BIB0192|cit192","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD007746.pub2-BIB0193|cit193","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"10","key":"10.1002\/14651858.CD007746.pub2-BIB0194|cit194","doi-asserted-by":"crossref","first-page":"781","DOI":"10.7326\/0003-4819-141-10-200411160-00009","article-title":"Better reporting of harms in randomized trials: an extension of the CONSORT statement","volume":"141","author":"Ioannidis","year":"2004","journal-title":"Annals of Internal Medicine"},{"issue":"2","key":"10.1002\/14651858.CD007746.pub2-BIB0195|cit195","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1600-6143.2009.02949.x","article-title":"Predicting coronary heart disease after kidney transplantation: Patient Outcomes in Renal Transplantation (PORT) Study","volume":"10","author":"Israni","year":"2010","journal-title":"American Journal of Transplantation"},{"issue":"9","key":"10.1002\/14651858.CD007746.pub2-BIB0196|cit196","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1097\/TP.0b013e3181d0e15e","article-title":"Treatment of polyomavirus infection in kidney transplant recipients: a systematic review","volume":"89","author":"Johnston","year":"2010","journal-title":"Transplantation"},{"issue":"8","key":"10.1002\/14651858.CD007746.pub2-BIB0197|cit197","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1432-2277.2006.00330.x","article-title":"Post-transplant de novo malignancies in renal transplant recipients: the past and present","volume":"19","author":"Kauffman","year":"2006","journal-title":"Transplant International"},{"key":"10.1002\/14651858.CD007746.pub2-BIB0198|cit198","first-page":"S1","article-title":"KDIGO clinical practice guideline for the care of kidney transplant recipients","volume":"9 Suppl 3","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group","year":"2009","journal-title":"American Journal of Transplantation"},{"issue":"10","key":"10.1002\/14651858.CD007746.pub2-BIB0199|cit199","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1001\/jama.298.10.1209","article-title":"Limitations of applying summary results of clinical trials to individual patients: the need for risk stratification","volume":"298","author":"Kent","year":"2007","journal-title":"JAMA"},{"issue":"6","key":"10.1002\/14651858.CD007746.pub2-BIB0200|cit200","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1097\/TP.0b013e3181952623","article-title":"Mycophenolate mofetil decreases acute rejection and may improve graft survival in renal transplant recipients when compared with azathioprine: a systematic review","volume":"87","author":"Knight","year":"2009","journal-title":"Transplantation"},{"issue":"7568","key":"10.1002\/14651858.CD007746.pub2-BIB0201|cit201","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1136\/bmj.333.7568.597","article-title":"The case of the misleading funnel plot","volume":"333","author":"Lau","year":"2006","journal-title":"BMJ"},{"issue":"16","key":"10.1002\/14651858.CD007746.pub2-BIB0202|cit202","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.2165\/11319260-000000000-00000","article-title":"Immunosuppressive drugs in kidney transplantation: impact on patient survival, and incidence of cardiovascular disease, malignancy and infection","volume":"69","author":"Marcen","year":"2009","journal-title":"Drugs"},{"issue":"8","key":"10.1002\/14651858.CD007746.pub2-BIB0203|cit203","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1097\/01.TP.0000062833.14843.4B","article-title":"Mycophenolate mofetil versus azathioprine therapy is associated with a significant protection against long-term renal allograft function deterioration","volume":"75","author":"Meier-Kriesche","year":"2003","journal-title":"Transplantation"},{"issue":"9128","key":"10.1002\/14651858.CD007746.pub2-BIB0204|cit204","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0140-6736(98)01085-X","article-title":"Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?","volume":"352","author":"Moher","year":"1998","journal-title":"Lancet"},{"issue":"9263","key":"10.1002\/14651858.CD007746.pub2-BIB0205|cit205","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0140-6736(00)04337-3","article-title":"The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials","volume":"357","author":"Moher","year":"2001","journal-title":"Lancet"},{"issue":"6","key":"10.1002\/14651858.CD007746.pub2-BIB0206|cit206","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1097\/01.ASN.0000126194.77004.9B","article-title":"Malignancy in renal transplantation","volume":"15","author":"Morath","year":"2004","journal-title":"Journal of the American Society of Nephrology"},{"issue":"5475","key":"10.1002\/14651858.CD007746.pub2-BIB0207|cit207","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1136\/bmj.2.5475.1387","article-title":"Human cadaveric renal transplantation. Report of twenty cases","volume":"2","author":"Mowbray","year":"1965","journal-title":"British Medical Journal"},{"issue":"8","key":"10.1002\/14651858.CD007746.pub2-BIB0208|cit208","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJMra011295","article-title":"Strategies to improve long-term outcomes after renal transplantation","volume":"346","author":"Pascual","year":"2002","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD007746.pub2-BIB0209|cit209","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0895-4356(99)00220-6","article-title":"Location bias in controlled clinical trials of complementary\/alternative therapies","volume":"53","author":"Pittler","year":"2000","journal-title":"Journal of Clinical Epidemiology"},{"issue":"5","key":"10.1002\/14651858.CD007746.pub2-BIB0210|cit210","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/TP.0b013e318197c17d","article-title":"The decade of polyomavirus BK-associated nephropathy: state of affairs","volume":"87","author":"Ramos","year":"2009","journal-title":"Transplantation"},{"issue":"19","key":"10.1002\/14651858.CD007746.pub2-BIB0211|cit211","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1001\/jama.295.19.2270","article-title":"Reported outcomes in major cardiovascular clinical trials funded by for-profit and not-for-profit organizations: 2000-2005. [Erratum appears in JAMA. 2006 Jun 21;295(23):2726]","volume":"295","author":"Ridker","year":"2006","journal-title":"JAMA"},{"issue":"2","key":"10.1002\/14651858.CD007746.pub2-BIB0212|cit212","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1046\/j.1600-6143.2003.00337.x","article-title":"Enteric-coated mycophenolate sodium is therapeutically equivalent to mycophenolate mofetil in de novo renal transplant patients","volume":"4","author":"Salvadori","year":"2004","journal-title":"American Journal of Transplantation"},{"issue":"7","key":"10.1002\/14651858.CD007746.pub2-BIB0213|cit213","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.jclinepi.2003.12.001","article-title":"Meta-regression detected associations between heterogeneous treatment effects and study-level, but not patient-level, factors","volume":"57","author":"Schmid","year":"2004","journal-title":"Journal of Clinical Epidemiology"},{"issue":"9","key":"10.1002\/14651858.CD007746.pub2-BIB0214|cit214","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1111\/j.1600-6143.2009.02756.x","article-title":"AZA\/tacrolimus is associated with similar outcomes as MMF\/tacrolimus among renal transplant recipients","volume":"9","author":"Schold","year":"2009","journal-title":"American Journal of Transplantation"},{"issue":"12","key":"10.1002\/14651858.CD007746.pub2-BIB0215|cit215","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1097\/01.tp.0000252683.74584.29","article-title":"Pregnancy outcomes in solid organ transplant recipients with exposure to mycophenolate mofetil or sirolimus","volume":"82","author":"Sifontis","year":"2006","journal-title":"Transplantation"},{"issue":"3","key":"10.1002\/14651858.CD007746.pub2-BIB0216|cit216","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/ki.2008.580","article-title":"Rates of first infection following kidney transplant in the United States","volume":"75","author":"Snyder","year":"2009","journal-title":"Kidney International"},{"issue":"2 Suppl","key":"10.1002\/14651858.CD007746.pub2-BIB0217|cit217","doi-asserted-by":"crossref","first-page":"S211","DOI":"10.1097\/01.tp.0000186379.15301.e5","article-title":"The impact of mycophenolate mofetil on long-term outcomes in kidney transplantation","volume":"80","author":"Srinivas","year":"2005","journal-title":"Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD007746.pub2-BIB0218|cit218","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2165\/00003088-200746010-00002","article-title":"Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients","volume":"46","author":"Staatz","year":"2007","journal-title":"Clinical Pharmacokinetics"},{"key":"10.1002\/14651858.CD007746.pub2-BIB0219|cit219","doi-asserted-by":"crossref","first-page":"d4002","DOI":"10.1136\/bmj.d4002","article-title":"Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials","volume":"343","author":"Sterne","year":"2011","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD007746.pub2-BIB0220|cit220","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1146\/annurev.med.58.061705.145143","article-title":"Why hasn't eliminating acute rejection improved graft survival?","volume":"58","author":"Tantravahi","year":"2007","journal-title":"Annual Review of Medicine"},{"issue":"9","key":"10.1002\/14651858.CD007746.pub2-BIB0221|cit221","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.jclinepi.2005.01.006","article-title":"In an empirical evaluation of the funnel plot, researchers could not visually identify publication bias","volume":"58","author":"Terrin","year":"2005","journal-title":"Journal of Clinical Epidemiology"},{"issue":"10","key":"10.1002\/14651858.CD007746.pub2-BIB0222|cit222","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1111\/j.1600-6143.2009.02802.x","article-title":"Subgroup analyses in randomized controlled trials: the need for risk stratification in kidney transplantation","volume":"9","author":"Wagner","year":"2009","journal-title":"American Journal of Transplantation"},{"key":"10.1002\/14651858.CD007746.pub2-BIB0223|cit223","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1471-2288-9-80","article-title":"Meta-Analyst: software for meta-analysis of binary, continuous and diagnostic data","volume":"9","author":"Wallace","year":"2009","journal-title":"BMC Medical Research Methodology"},{"key":"10.1002\/14651858.CD007746.pub2-BIB0224|cit224","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1016\/j.transproceed.2004.07.059","article-title":"Efficacy of mycophenolate mofetil versus azathioprine after renal transplantation: a systematic review","volume":"36","author":"Wang","year":"2004","journal-title":"Transplantation Proceedings"},{"issue":"7","key":"10.1002\/14651858.CD007746.pub2-BIB0225|cit225","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1016\/j.transproceed.2004.07.057","article-title":"Safety of mycophenolate mofetil versus azathioprine in renal transplantation: a systematic review","volume":"36","author":"Wang","year":"2004","journal-title":"Transplantation Proceedings"},{"issue":"5","key":"10.1002\/14651858.CD007746.pub2-BIB0226|cit226","first-page":"365","article-title":"Safety of mycophenolate mofetil versus azathioprin in renal transplantation: a systematic review","volume":"5","author":"Wang","year":"2005","journal-title":"Chinese Journal of Evidence-Based Medicine"},{"issue":"7520","key":"10.1002\/14651858.CD007746.pub2-BIB0227|cit227","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1136\/bmj.38569.471007.AE","article-title":"Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data","volume":"331","author":"Webster","year":"2005","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD007746.pub2-BIB0228|cit228","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004290.pub2","article-title":"Target of rapamycin inhibitors (TOR-I; sirolimus and everolimus) for primary immunosuppression in kidney transplant recipients","author":"Webster","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"12","key":"10.1002\/14651858.CD007746.pub2-BIB0229|cit229","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1038\/sj.ki.5002154","article-title":"The janus face of immunosuppression - de novo malignancy after renal transplantation: the experience of the Transplantation Center Munich","volume":"71","author":"Wimmer","year":"2007","journal-title":"Kidney International"},{"issue":"2","key":"10.1002\/14651858.CD007746.pub2-BIB0230|cit230","first-page":"79","article-title":"Systematic review of randomized controlled trials about comparison mycophenolate mofetil and azathioprine after renal transplantation","volume":"4","author":"Zhang","year":"2004","journal-title":"Chinese Journal of Evidence-Based Medicine"},{"issue":"2","key":"10.1002\/14651858.CD007746.pub2-BIB0231|cit231","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007746","article-title":"Mycophenolic acid versus azathioprine as primary immunosuppression for kidney transplant recipients","author":"Wagner","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD007746.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T16:22:28Z","timestamp":1712074948000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD007746.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Kidney and Transplant Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,12,3]]},"references-count":231,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2015,12]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd007746.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,3]]}}}